Celero Systems is radically transforming the healthcare industry by creating an ingestible “digital pill” capable of monitoring heart rate, breathing and core temperature directly from the stomach. This remarkable innovation aims to identify early signs of sleep apnea, heart problems and cases of opioid overdose. According to information from the Wired portal, this technology represents an advanced approach to monitoring chronic conditions, marking a significant advance in internal health monitoring.
Discreet Monitoring at Home:
The company initially envisions using the digital capsule to allow individuals with chronic conditions to monitor their vital signs at home. Unlike traditional methods that involve overnight hospital stays, the capsule offers a more convenient and affordable solution. In a recent clinical study, the device demonstrated accuracy comparable to polysomnography, without the drawbacks associated with conventional methods.
Tecnologia de Ponta
The capsule, although commonly referred to as a “pill,” is actually a biocompatible plastic capsule containing tiny sensors, microprocessor, radio antenna and batteries. Developed by Celero Systems, known for its CEO Ben Pless, with experience in medical implants, the capsule offers the benefits of implants in a discreet and non-invasive way.
Future Applications and Transformative Potential
In addition to sleep apnea monitoring, the company believes the tablet has broad potential applications. It can be used to monitor sporadic cardiac and respiratory events, such as asthma attacks, atrial fibrillation, and neuromuscular disorders. Future vision includes the ability for doctors to send the capsule to patients for remote monitoring of vital signs.
Opioid Overdose Detection
One of the pill’s most notable features is its potential ability to detect drug overdoses. In a scenario where breathing rates drop, the capsule can send alerts, enabling rapid intervention. This function is particularly crucial in situations where immediate administration of Narcan can save lives.
Promising Studies
Preliminary human trials showed promising results, with participants in a residential treatment program swallowing the capsule with no side effects. The company also conducted animal tests, demonstrating the pill’s ability to detect overdoses and release medication. Human trials for this functionality are planned for 2024.
The Future of Health Monitoring
While wearable devices like Fitbits are common, Celero Systems believes the tablet offers a safer and more reliable solution, especially for those in active recovery. The company is optimistic about the capsule’s significant potential to transform the way we monitor, diagnose and treat disease, highlighting its revolutionary role at the forefront of healthcare innovation.
( fonte: C.T. Carvalho/ digital agro )
